banner

Latest News

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) and Fast Track Designations for RP-L102 Gene Therapy for Fanconi Anemia

From Business Wire:NEW YORK--Nov. 27, 2018-- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, today announces that the U.S. Food and Drug Administration (FDA) has granted Regenerative Medicine Advanced Therapy (RMAT) and Fast Track designations to RP-L102, the Company’s lentiviral vector (LVV)-based gene therap...

Read More

Evonetix "Highly Commended" at Cambridge Independent Science and Technology Awards 2018

From Cambridge Independent Science and Technology Awards 2018: Evonetix Highly CommendedThe winners of the 2018 Cambridge Independent Science and Technology Awards were unveiled at a ceremony at the Hilton City Centre Hotel hosted by editor Paul Brackley, who chaired the judging panel for the awards.HIGHLY COMMENDED, Startup of the Year Award: EvonetixEvonetix, based on Chesterford Research Par...

Read More

Silicone Valley Bank: Trends in Healthcare Investments and Exits 2018

A recent report by SVB highlights Civilization Ventures on page 19: Almost any way you look at it, 2018 was a record year for life science and healthcare companies. We saw new levels of venture fundraising, total investment values, acquisitions and initial public offerings.Highlights in 2018 include:US healthcare venture fundraising reaches $9.6 billion —a record.US and EU VC investment in l...

Read More


Blood Test to Detect Prenatal Genetic Defects to Soon be a Reality

A recent article on BillionToOne: A unique healthcare innovation by a young Indian scientist has the potential to radically change how prenatal genetic testing is done to identify fetal abnormalities. FIT interviews Sukrit Silas, a PhD from Stanford and the Chief Science Officer at BillionToOne, a Y Combinator Company. They’ve developed a non-invasive pre...

Read More


Evonetix named Best Synthetic Biology Company at OBN Awards

From Evonetix:EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, has received the award for “Best Emerging Synthetic Biology Company” at the 10th Anniversary of the Oxford Bioscience Network (OBN) Awards, in recognition of the Company’s novel gene synthesis technology, and its potential to facilitate the ra...

Read More

PRESS RELEASE: Diabetes Prevention Program Helps Hurricane Harvey Survivors

From Omada Health:Stamford, Conn. — Oct. 10, 2018— Americares has launched a new digital diabetes prevention program to improve the health of low-income patients in hurricane-impacted communities. The health-focused relief organization is partnering with digital medicine company Omada Health to enroll Texas patients from free clinics in a year-long diabetes prevention program. “Untrea...

Read More

The DNA data storage machine that’s the size of a school bus

From MIT Technology Review: The DNA data storage machine that’s the size of a school bus   by Antonio Regalado In a world awash with data, DNA is a hugely compact way to store it. The data on every iPhone, PC, and server rack on the planet could fit in a Jacuzzi’s worth of genetic letters, for example. It’s also incredibly durable: DNA can last for thousands of years so...

Read More

Evonetix partner with LioniX International to enable DNA synthesis at scale

From Evonetix:EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to scalable and high-fidelity gene synthesis, and LioniX International, a leading global provider of customised microsystem solutions in scalable production volumes, will collaborate to scale up production of prototype microelectromechanical systems (MEMs) for DNA synthesis. LioniX Internation...

Read More